NGGT002

GENETIC2 trials

Sponsors

NGGT INC., NGGT (Suzhou) Biotechnology Co., Ltd.

Conditions

Phenylketonurias

Phase 1

AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)

RecruitingNCT06332807

NGGT INC.Phenylketonurias

Start: 2025-01-10End: 2030-12-30Target: 12Updated: 2026-08-18

Safety and Efficacy Study of NGGT002 in Adult Patients With Phenylketonuria

RecruitingNCT06687733

NGGT (Suzhou) Biotechnology Co., Ltd.Phenylketonurias

Start: 2024-07-16End: 2030-06-11Target: 18Updated: 2026-08-13